Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade
Biomolecules · 2025
DOI: 10.3390/biom15111573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Toshifumi Hara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, School of Pharmacy, Aichi Gakuin University, Nagoya 464-8650, Japan. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Science Foundation.
Abstract (Originalsprache)
Metastasis is the leading cause of cancer-related mortality, representing a highly coordinated, multistep process in which malignant cells gain the ability to invade, survive in the circulation, and establish secondary tumors at distant sites. While genetic mutations initiate oncogenesis, accumulating evidence shows that epigenetic and epitranscriptomic regulators, encompassing DNA methylation, RNA modifications, and noncoding RNAs (ncRNAs), reshape metastatic phenotypes. This review integrates current insights into these mechanisms and their crosstalk, with a primary focus on their methylation modification. Given their plasticity and potential reversibility, these regulators are attractive targets for therapeutic intervention. Defining the dynamic interplay between DNA and RNA modifications and ncRNAs provides a coherent framework for controlling metastasis and guides the development of precision epigenetic strategies and biomarkers. Future research that integrates multi-omics approaches and spatial transcriptomics will be essential for revealing the epigenetic and epitranscriptomic layers of the metastatic landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, School of Pharmacy, Aichi Gakuin University, Nagoya 464-8650, Japan.
- Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY 10065, USA.
- Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha 24144, Qatar.
ORCID-Profile: Murugan Subramanian
Förderung
- Takeda Science Foundation
Zitieren
APA
Hara, T., & Subramanian, M. (2025). Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade. Biomolecules. https://doi.org/10.3390/biom15111573
Vancouver
Hara T, Subramanian M. Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade. Biomolecules. 2025. doi:10.3390/biom15111573
BibTeX
@article{Hara2025,
author = {Hara, Toshifumi and Subramanian, Murugan},
title = {Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15111573}
}
EUVIMED